Search Results - "Pyrotinib"

Hollow Mesoporous Selenium Nanoparticles Loaded with Pyrotinib and Coated with Trastuzumab-Functionalized Albumin for Targeted Therapy of HER2-Positive Breast Cancer

Du, Jiaqun^aff2, Sun, Junpeng^aff2, Liu, Xiaobang^aff2, Shi, Huan^aff2, Wu, Chao^aff2, Liu, Ying^aff2, Qiu, Yang^aff2, Gao, Yu^aff1

Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer.

Wang, Chaokun, Deng, Shuzhen, Chen, Jing, Xu, Xiangyun, Hu, Xiaochen, Kong, Dejiu, Liang, Gaofeng, Yuan, Xiang, Li, Yuanpei, Wang, Xinshuai

application/pdf

Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study

Han H, Wang C, Jiang F, Sun P, Liu J

electronic resource

View item; View item

Pyrotinib as a salvage treatment for patients with HER-2 positive advanced lung adenocarcinoma after the progression of afatinib treatment

Xu, Manyi^{Aff1, Aff3, Aff4}, Wang, Yanhua^{Aff1, Aff3, Aff4}, Shao, Keda^{Aff2, Aff3, Aff4}, Hao, Yue^{Aff3, Aff4}, Song, Zhengbo^{Aff3, Aff4, IDs12094024034829_cor5}

Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review

Tao Wang, Mingyuan He, Wei Guan

electronic resource

View item

A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast Cancer

Yang Z, Fu WD, Gu HY, Ding JL, Guo GL

electronic resource

View item; View item

Mechanism of Atractylenolide Ⅲ alleviating pyrotinib-induced diarrhea by regulating AMPK/CFTR pathway through metabolite of gut microbiota

Fengxian Jiang, Pancen Ran, Liyin Pan, Jingjiang Lai, Junlei Zhang, Jing Zhao, Wei Xu, Jingliang Wang, Yang Shu, Yahui Wang, Rui Zhao, Weihao Wang, Jian Wei, Guobin Fu

electronic resource

View item; View item

Development of a risk prediction nomogram model of pyrotinib-induced severe diarrhea

Qingqing Chen, Guoding Huang, Yaowen Xia, Hongmei Zhao, Yu zheng, Yiyi Liao

electronic resource

View item

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting

Jian Zhang, Yuxin Mu, Hui Zhang, Chao Deng, Jiao Yang, Lu Gan, Qingmo Yang, Xuefeng Xu, Wanping Liang, Xiaowei Qi, Liang Xu

electronic resource

View item; View item

Evaluation of the pharmacokinetic interactions of montmorillonite powder or loperamide on pyrotinib in healthy volunteers

Yike Wang, Dai Li, Tong Zhang, Sumei Xu, Yanxin Zhang, Kaijing Zhao, Shaorong Li, Kai Shen, Xiaomin Li, Pingsheng Xu

electronic resource

View item; View item

Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer

Yongxia Li, Yong Li, Taolang Li, Mingyuan He, Jianying Chang, Hui Cao, Daiqin Luo, Junyuan Lv, Yunbi Zou, Yuyan Zheng, Li Ran, Feiyue Yang, Li Huang, Xiaoming Cheng

electronic resource

View item; View item

Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial

Feilin Cao, Zhaosheng Ma, Zenggui Wu, Weizhu Wu, Ouchen Wang, Binbin Cui, Xiaotao Zhu, Jing Hao, Xiaochun Ji, Zhanwen Li, Deyou Tao, Qingjing Feng, Wei Lin, Dongbo Shi, Jingde Shu, Jichun Zhou, Shifen Huang

electronic resource

View item; View item

Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study

Jiaxuan Liu, Maiyue He, Mingxia Jiang, Shihan Zhou, Mengqi Zhang, Yiqun Li, Shanshan Chen, Ruigang Cai, Hongnan Mo, Bo Lan, Fei Ma, Binghe Xu, Qiao Li

electronic resource

View item

The efficacy and potential mechanisms of pyrotinib in targeting EGFR and HER2 in advanced oral squamous cell carcinoma

Zhou, Liang, Le, Kehao, Chen, Qianming, Wang, Huiming^{Aff2, IDs12903024044594_cor4}

Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer

Du, Jiaqun, Liu, Xiaobang, Sun, Junpeng, Wu, Qian, Hu, Yu, Shi, Huan, Zheng, Li, Liu, Ying^{Aff2, IDs13058024018532_cor8}, Wu, Chao^{Aff2, IDs13058024018532_cor9}, Gao, Yu^{Aff1, IDs13058024018532_cor10}

Pyrotinib Plus Taxanes or Vinorelbine for the Treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Prospective Evaluation of Efficacy and Safety

Xiong, Weili ¹, Sun, Jiukang ², Gu, Quan ³, Xu, Ting ³, Zhang, Lili ⁴, Yuan, Yuan ^{4, ⁎}

Polysaccharide from Atractylodes macrocephala Koidz. alleviates pyrotinib-induced diarrhea through regulating cAMP/LKB1/AMPK/CFTR pathway and restoring gut microbiota and metabolites

Ran, Pancen ^{a, b, 1}, Jiang, Fengxian ^{d, 1}, Pan, Liying ^{b, 1}, Shu, Yang ^b, Hu, Fangyan ^c, Wang, Yahui ^b, Zhao, Rui ^a, Wang, Weihao ^a, Mu, Huaiqian ^a, Wang, Juqiong ^c, Wei, Jian ^{c, ⁎}, Fu, Guobin ^{a, b, e, ⁎⁎}

Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer

Chaokun Wang, Shuzhen Deng, Jing Chen, Xiangyun Xu, Xiaochen Hu, Dejiu Kong, Gaofeng Liang, Xiang Yuan, Yuanpei Li, Xinshuai Wang

electronic resource

View item; View item

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report

Jianxin Chen, Jian Wang, Qinhong Zheng

electronic resource

View item; View item

Pyrotinib-assisted whole brain radiotherapy alleviates HER2-positive advanced breast cancer and brain metastases: a prospective study in patients

Fulin Zhou, Cui Zhang, Mingyuan He, Yu Ren, Hongshuang Yue, Zhihua Tan, Shaolin Zhang, Yong Li, Shu Liu

electronic resource

View item; View item